319 related articles for article (PubMed ID: 22797180)
21. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.
Banda NK; Hyatt S; Antonioli AH; White JT; Glogowska M; Takahashi K; Merkel TJ; Stahl GL; Mueller-Ortiz S; Wetsel R; Arend WP; Holers VM
J Immunol; 2012 Feb; 188(3):1469-78. PubMed ID: 22205026
[TBL] [Abstract][Full Text] [Related]
22. The proinflammatory mediators C3a and C5a are essential for liver regeneration.
Strey CW; Markiewski M; Mastellos D; Tudoran R; Spruce LA; Greenbaum LE; Lambris JD
J Exp Med; 2003 Sep; 198(6):913-23. PubMed ID: 12975457
[TBL] [Abstract][Full Text] [Related]
23. Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB/c mice.
Zhang JX; Zha WS; Ye LP; Wang F; Wang H; Shen T; Wu CH; Zhu QX
J Appl Toxicol; 2016 Feb; 36(2):271-84. PubMed ID: 26095957
[TBL] [Abstract][Full Text] [Related]
24. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
Ramos TN; Wohler JE; Barnum SR
Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
[TBL] [Abstract][Full Text] [Related]
25. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
Strainic MG; Shevach EM; An F; Lin F; Medof ME
Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
[TBL] [Abstract][Full Text] [Related]
26. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
27. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
28. The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.
Rong S; Park JK; Kirsch T; Yagita H; Akiba H; Boenisch O; Haller H; Najafian N; Habicht A
J Am Soc Nephrol; 2011 Mar; 22(3):484-95. PubMed ID: 21355054
[TBL] [Abstract][Full Text] [Related]
29. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
[TBL] [Abstract][Full Text] [Related]
30. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
[TBL] [Abstract][Full Text] [Related]
31. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.
Wu MC; Brennan FH; Lynch JP; Mantovani S; Phipps S; Wetsel RA; Ruitenberg MJ; Taylor SM; Woodruff TM
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9439-44. PubMed ID: 23696668
[TBL] [Abstract][Full Text] [Related]
32. [Levels of complement components C3a and C5a in renal injury among trichloroethylene-sensitized BALB/c mice].
Zha W; Leng J; Wang F; Zhang J; Li S; Wang H; Shen T; Zhu Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):335-9. PubMed ID: 25169086
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
34. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
35. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.
Shah TA; Nejad JE; Pallera HK; Lattanzio FA; Farhat R; Kumar PS; Hair PS; Bass WT; Krishna NK
Pediatr Res; 2017 Apr; 81(4):654-662. PubMed ID: 28002390
[TBL] [Abstract][Full Text] [Related]
37. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury.
Zheng X; Zhang X; Feng B; Sun H; Suzuki M; Ichim T; Kubo N; Wong A; Min LR; Budohn ME; Garcia B; Jevnikar AM; Min WP
Am J Pathol; 2008 Oct; 173(4):973-80. PubMed ID: 18772341
[TBL] [Abstract][Full Text] [Related]
38. The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response to
Mueller-Ortiz SL; Calame DG; Shenoi N; Li YD; Wetsel RA
J Immunol; 2017 Apr; 198(8):3237-3244. PubMed ID: 28275134
[No Abstract] [Full Text] [Related]
39. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
